Field Exchange 42, launched online this week, ([url]http://www.ennonline.net/fex/[/url]) includes an article on ACF’s position paper on the use of products for the treatment of severe acute malnutrition (SAM) and the prevention and treatment of moderate acute malnutrition (MAM). Many agencies are currently in a position of having to make decisions on whether, when and how to use the increasing range of available products designed to treat or prevent MAM. What is your experience with their use or your thoughts on this topic? Is there a place for products in the prevention of MAM or should the focus be on scale up of food-based approaches? Should products for the treatment or prevention of MAM be reserved for humanitarian responses or specific groups such as people living with HIV/AIDS, IDPs, refugees or camp settings, or is there a place for their use in more stable contexts? Should they be prescribed or generally available? Can they ever be anything more than a short term measure?